Hosted on MSN
Novo Nordisk plans Wegovy vial launch to counter Eli Lilly, target broader obesity market
Novo Nordisk A/S NVO plans to start selling its blockbuster obesity drug Wegovy in vials, marking its latest effort to strengthen its position against rival Eli Lilly and Co. LLY as competition ...
And check out Free: "American Prophets -- Writers, Religion and Culture" on the Highland Park Patch calendar ...
Ninth Circuit Allows FCA Claim Based on Alleged Violations of Section 340B Program Davis Wright Tremaine LLP on 3/25/2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results